K+N invests in overland pharma fleet
05 / 09 / 2018
Kuehne + Nagel (K+N) is strengthening its European pharma fleet as the market for temperature-controlled shipments continues to grow.
The forwarder has deployed 35 new pharma trailers and will add a further 45 before the end of this year – plus another 200 in the coming years – in order to ensure its PharmaChain overland service provides sufficient capacity as part of a multimodal door-to-door solution for the region’s pharma industry.
Uwe Hött, senior vice president overland, said: “Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s overland and regional business.
“This investment is part of our commitment to provide comprehensive, GxP compliant transport solutions for the industry, which can be tailored to specific needs.”
Read more pharma logistics news